<?xml version="1.0" encoding="UTF-8"?>
<p id="Par17">Remdesivir is a large-scale intravenous antiviral investigative drug that inhibits viral replication by premature termination of RNA transcription and has in vitro activity against SARS-CoV-2 and in vitro and in vivo activity against related beta coronaviruses (Mulangu et al. 
 <xref ref-type="bibr" rid="CR11">2019</xref>).
</p>
